Picture of Anika Therapeutics logo

ANIK Anika Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Anika Therapeutics Inc Reports Quarterly Loss Per Share Of $0.29

Nov 8 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
    * ANIKA THERAPEUTICS INC - REVENUE IN Q3 OF 2022 WAS $40.3
MILLION, UP 2%
    * ANIKA THERAPEUTICS INC - QUARTER LOSS PER SHARE OF $0.29
    * ANIKA THERAPEUTICS INC - QTRLY ADJUSTED NET LOSS OF $0.05
PER
SHARE
    * ANIKA THERAPEUTICS INC - QUARTER ENDING CASH WAS $87.8
MILLION

Source text for Eikon:  ID:nGNX9tlYqg 
Further company coverage:  ANIK.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Anika Therapeutics

See all news